Conditions:   Bone Metastases in Men With Hormone-Refractory Prostate Cancer;   Bone Metastases in Subjects With Advanced Breast Cancer
Intervention:   Drug: denosumab
Sponsor:   Amgen
Enrolling by invitation - verified August 2011